Cardiac, renal, and metabolic effects of sodium–glucose co‐transporter 2 inhibitors: a position paper from the European Society of Cardiology ad‐hoc task force on sodium–glucose co‐transporter 2 inhibitors-Reference-Cited by-同舟云学术

Cardiac, renal, and metabolic effects of sodium–glucose co‐transporter 2 inhibitors: a position paper from the European Society of Cardiology ad‐hoc task force on sodium–glucose co‐transporter 2 inhibitors

Published:2021-07-20 Issue:8 Volume:23 Page:1260-1275
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Herrington William G.¹²,Savarese Gianluigi³,Haynes Richard¹²,Marx Nikolaus⁴,Mellbin Linda³,Lund Lars H.³,Dendale Paul⁵⁶,Seferovic Petar⁷,Rosano Giuseppe⁸,Staplin Natalie¹,Baigent Colin¹,Cosentino Francesco³

Affiliation:

1. Medical Research Council Population Health Research Unit at the University of Oxford, part of the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (NDPH) University of Oxford Oxford UK

2. Oxford Kidney Unit Churchill Hospital Oxford UK

3. Cardiology Unit, Department of Medicine Karolinska Institute: Heart and Vascular Theme, Karolinska University Hospital Stockholm Sweden

4. Department of Internal Medicine University Hospital Aachen, RWTH Aachen University Aachen Germany

5. Heart Centre Hasselt, Jessa Hospital Hasselt Belgium

6. Faculty of Medicine & Life Sciences Hasselt University Hasselt Belgium

7. Faculty of Medicine University of Belgrade Belgrade Serbia

8. Department of Medical Sciences IRCCS San Raffaele Pisana Rome Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link